Efficiency of allergen specific immunotherapy in children with atopic dermatitis combined with the pathology of the upper gastrointestinal tract
Background. In the structure of dermatological morbidity, the specific weight of atopic dermatitis (AD) is up to 20.0 %. The severity of AD correlates with the lesion of the gastrointestinal tract. In the opinion of almost all immunology and allergology specialists, allergen specific immunotherapy (ASIT) is the only method that is able to influence all links of the pathological process. The purpose was to determine the effectiveness of the ASIT in children with atopic dermatitis combined with the pathology of the upper gastrointestinal tract. Materials and methods. The paper presents data of clinical observation, clinical laboratory and instrumental examination of 168 children aged 7 to 18 years with AD combined with chronic gastroduodenitis (CGD). A comparative evaluation of the different treatment options was carried out in 50 children: the main group of 25 children with AD and CGD who, along with the traditional therapy as a part of outpatient treatment, underwent ASIT according to the standard schedule during the year, the comparison group consisted of 25 children with combined pathology who received standard therapy. Results. Clinical symptoms in children with CGD combined with AD were characterized by the presence of leading syndromes: pain (98.8 ± 8.9 % of patients), dyspepsia (91.6 ± 11.2 % of persons), intoxication (79.1 ± 7.2 % of patients) and cutaneous (100 %). In the group of children receiving ASIT, the mean levels of the Scoring Atopic Dermatitis index decreased by 61.8 % three months after treatment, and one year after the treatment — by 42.6 %. The corresponding indices in the comparison group decreased by 41.3 and 24.9 %, respectively (р < 0.05). The use of comprehensive treatment in children with AD and CGD reduced by 27.8 % the period of pain relief, by 14.0 % — of dyspepsia and by 25.0 % — of asthenovegetative syndromes. It was found that the relative risk of disease recurrence will decrease by 0.48 times (c2 = 3.96, p < 0.05) when this therapy is included in the treatment regimen. Conclusions. The clinical study demonstrated the positive effect of comprehensive treatment with the inclusion of ASIT on the clinical course of AD combined with CGD. The proposed comprehensive therapy was more effective than traditional treatment even in long-term follow-up.
Full Text:PDF (Українська)
Dudnikova EV, Kobzeva NN, Prihodskaja ES, Besedina EA, Pedchenko EG. Сertain peculiarities of the clinical course of atopic dermatitis in children's early age. Meditsinskiy vestnik Yuga Rossii. 2013;(3):44-47. (in Russian).
Repetskaya MN, Maslov YuN, Shaydullina EV. Clinicolaboratory characteristic of complicated and uncomplicated forms of atopic dermatitis in children. Ural'skii meditsinskii zhurnal. 2011;(80):105-108. (in Russian).
Melnikov VL, Rybalkin SB, Mitrofanova NN, Ageykin AV. Some clinical and epidemiological aspects of the flow of atopic dermatitis on the territory of the Penza region. Fundamental Research. 2014;(10-5):936-940. (in Russian).
Ballow M, Akdis CA, Casale TB, et al. Immune response modifiers in the treatment of asthma: A PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology. J Allergy Clin Immunol. 2012 Aug;130(2):311-24. doi: 10.1016/j.jaci.2012.04.046.
Bae JM, Choi YY, Park CO, Chung KY, Lee KH. Efficacy of allergen-specific immunotherapy for atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials. J Allergy Clin Immunol. 2013 Jul;132(1):110-7. doi: 10.1016/j.jaci.2013.02.044.
Berings M, Karaaslan C, Altunbulakli C, et al. Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance. J Allergy Clin Immunol. 2017 Nov;140(5):1250-1267. doi: 10.1016/j.jaci.2017.08.025.
Simpson EL, Chalmers JR, Hanifin JM, et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol. 2014 Oct;134(4):818-23. doi: 10.1016/j.jaci.2014.08.005.
Copyright (c) 2018 CHILD`S HEALTH
This work is licensed under a Creative Commons Attribution 4.0 International License.
© Publishing House Zaslavsky, 1997-2019